Detalles de la búsqueda
1.
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling.
Br J Haematol
; 203(3): 416-425, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37580908
2.
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression.
Blood
; 135(15): 1244-1254, 2020 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32006000
3.
SF3B1-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulation
Haematologica
; 106(12): 3125-3135, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33121237
4.
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-ß and p-SMAD Pathway.
Biol Blood Marrow Transplant
; 26(5): 823-834, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32006713
5.
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation.
Transfusion
; 60(7): 1529-1535, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32488938
6.
Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs.
Ann Hematol
; 99(4): 867-875, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32036421
7.
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO).
Biol Blood Marrow Transplant
; 25(12): 2388-2397, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31400502
8.
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.
Am J Hematol
; 99(5): 982-984, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38343033
9.
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study.
Biol Blood Marrow Transplant
; 24(2): 267-275, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29128554
10.
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 24(12): 2450-2458, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30026107
11.
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi.
Biol Blood Marrow Transplant
; 24(9): 1814-1822, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29857196
12.
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia.
Hematol Oncol
; 41(3): 567-570, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36190298
13.
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia.
Am J Hematol
; 98(7): E157-E160, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37067157
14.
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study.
Am J Hematol
; 98(2): E24-E27, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36349541
15.
Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin.
Oncologist
; 22(4): 422-431, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28275118
16.
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
Hematol Oncol
; 39(4): 570-574, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34258787
17.
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials.
Am J Hematol
; 96(8): E269-E272, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33878220
18.
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases.
Am J Hematol
; 96(8): E306-E310, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33989438
19.
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.
Blood
; 122(25): 4111-8, 2013 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24152907
20.
Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey.
Cytotherapy
; 16(1): 101-10, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24169075